$ALNY $ARWR cross license. Arrowhead can develop HBV RNAi, Alnylam gets access to delivery tech: http://t.co/AvLToePo

$ALNY and $ARWR cross license agreement. Arrowhead can devel HBV RNAi drug and Alnylam gets access to new delivery tech http://t.co/qj6DkXjg

No time for a full post, but here is my collection of links and docs re $ARWR buying Roche's #RNAi assets: http://t.co/A9IpKr14

RT @chasingthealpha: wow $ARWR up 115% off weight loss data in obese MONKEYS! wtf is wrong with this market?

$ARWR pays Roche 50k note and 9m shares (trading at 0.46), plus some future considerations. Still going over filing: http://t.co/RwSBgDpC

$ARWR buys Roche RNAi assets including $TKMR and $ALNY licences: http://t.co/tdxSh9wB

$ARWR at $0.54... $0.55 is a massive b/o level

long more $ARWR...

bidding for more $ARWR...